Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gene Is a Risk Factor of Large-Vessel Atherosclerosis Stroke

• Shérine Abboud ,

  *To whom correspondence should be addressed. E-mail: shabboud@ulb.ac.be

  Affiliations Laboratory of Experimental Neurology, Department of Neurology, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium, Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Tampere University Hospital and Medical School, University of Tampere, Finland

  ⨯
• Pekka J. Karhunen,

  Affiliation School of Medicine, University of Tampere and Research Unit of the Laboratory Centre, Tampere University Hospital, Tampere, Finland

  ⨯
• Dieter Lütjohann,

  Affiliation Department of Clinical Pharmacology, University of Bonn, Bonn, Germany

  ⨯
• Sirkka Goebeler,

  Affiliation School of Medicine, University of Tampere and Research Unit of the Laboratory Centre, Tampere University Hospital, Tampere, Finland

  ⨯
• Teemu Luoto,

  Affiliation School of Medicine, University of Tampere and Research Unit of the Laboratory Centre, Tampere University Hospital, Tampere, Finland

  ⨯
• Silvia Friedrichs,

  Affiliation Department of Clinical Pharmacology, University of Bonn, Bonn, Germany

  ⨯
• Terho Lehtimaki,

  Affiliation Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Tampere University Hospital and Medical School, University of Tampere, Finland

  ⨯
• Massimo Pandolfo,

  Affiliation Laboratory of Experimental Neurology, Department of Neurology, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium

  ⨯
• Reijo Laaksonen

  Affiliations Laboratory of Experimental Neurology, Department of Neurology, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium, Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Tampere University Hospital and Medical School, University of Tampere, Finland

  ⨯